Tirzepatide — lab test, June 2026
COA COA-2026-412690 matches ILS Laboratories's public record. So this test doesn't rest on our review alone — the lab confirms it too.
9G03D66ATest results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 10 mg · Lab measured 10.32 mg
103% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.6 mg using the measured mass, against 2.5 mg on the label — 3% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | COA-2026-412690 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 16 Jul 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | ILS Laboratories's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tirzepatide, performed by ILS Laboratories on June 4, 2026. Reported purity: 99.85%. Net content: 10.32 mg against 10 mg labeled (103% of label). Endotoxins: NMT 0.05 EU/mL. Batch #HX4VN. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion